Global Veterinary Care Market Size study, by Animal Type (Companion, Production), by Type of Care (Primary, Critical) and Regional Forecasts 2022-2032

Global Veterinary Care Market is valued approximately at USD 87.3 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.00% over the forecast period 2024-2032. Veterinary care has evolved into a sophisticated ecosystem that blends clinical precision with emotional commitment, catering not just to livestock and economic imperatives but also to the deepening human-animal bond observed in companion animal populations. The modern veterinary landscape spans a broad continuum-from preventive diagnostics to advanced emergency and surgical interventions-each increasingly powered by cutting-edge technologies, telehealth, and evidence-based medicine. The growing demand for animal-derived food products, coupled with a surge in pet ownership, has carved a compelling trajectory for veterinary services that are both multifaceted and continuously innovating.

The market's upward momentum is largely driven by a confluence of factors: rising incidences of zoonotic diseases, increased public and governmental attention toward animal health, and the economic significance of livestock productivity. Companion animal owners, increasingly viewing pets as family, are fueling expenditure on wellness services, vaccinations, diagnostics, and even niche segments like physiotherapy and behavioral care. Meanwhile, production animal health remains mission-critical for ensuring global food security, pushing governments and large agri-businesses to invest heavily in primary and critical veterinary services aimed at herd health, outbreak prevention, and biosecurity compliance. Additionally, advances in digital platforms and AI-driven decision-support tools are dramatically enhancing clinical outcomes and optimizing resource use within veterinary settings.

While the potential is vast, the veterinary care market also wrestles with inherent challenges. High operational costs, an ongoing shortage of skilled veterinarians-especially in rural and developing regions-and limited public funding for veterinary infrastructure can hinder scalability and access. Furthermore, awareness gaps around animal disease prevention and a fragmented service delivery model in low-income nations continue to obstruct comprehensive care. Despite these roadblocks, the integration of mobile clinics, microinsurance models for livestock, and collaborative efforts between veterinary colleges and public health agencies are beginning to address these disparities.

As global animal health priorities shift toward sustainability and resilience, stakeholders are doubling down on research and innovation to redefine the role of veterinary care. From real-time monitoring of livestock through wearable devices to teleconsultations for pets in underserved areas, the boundaries of care are rapidly expanding. The interplay between veterinary and human health under the One Health framework is also gaining traction, amplifying the role of veterinarians in public health policy, surveillance, and antimicrobial resistance management.

Regionally, North America stands out as a frontrunner in the veterinary care market, underpinned by high pet healthcare spending, widespread insurance coverage, and technologically advanced veterinary hospitals. Europe follows closely, bolstered by stringent animal welfare regulations and an uptick in companion animal adoptions. Asia Pacific, however, is expected to exhibit the fastest growth over the forecast horizon, driven by population growth, increasing disposable incomes, and government programs aimed at improving livestock health outcomes in agriculture-dependent economies like India, China, and Vietnam. Latin America and the Middle East & Africa are also poised for stable expansion, supported by rural veterinary outreach initiatives and foreign investment in livestock health systems.

Major market player included in this report are:

• Mars Petcare Inc.
• IDEXX Laboratories, Inc.
• Zoetis Inc.
• CVS Group plc
• Elanco Animal Health Inc.
• Boehringer Ingelheim International GmbH
• Virbac
• VCA Animal Hospitals
• National Veterinary Associates
• Medivet Group Ltd
• PetIQ, Inc.
• AniCura Group
• Neogen Corporation
• Dechra Pharmaceuticals PLC
• Covetrus, Inc.

The detailed segments and sub-segment of the market are explained below:

By Animal Type

• Companion
• Production

By Type of Care

• Primary
• Critical

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical Year - 2022
• Base Year - 2023
• Forecast Period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.